Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Bernard Halloran, PhD

    TitleAdjunct Professor and Lecturer
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address4150 Clement St
    San Francisco CA 94121
    Phone415-575-0551
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Major programs in Dr. Halloran's laboratory include stem cell aging using animal models to study the effects of aging on stem cells and bone. Projects include work with natural products, development of orthopedic stem cell-based devices to facilitate spine fusion and bone healing. Students and postdoctoral fellows are encouraged to work collaboratively with other faculty in the Departments of Medicine, Bioengineering and Orthopedics.

      Additional Funding
      DoD, Osteoprogenitors in heterotopic ossification, 5/1/14
      The goal of this proposal is to identify the role of endothelial cell migration in trauma-induced heterotopic ossification
      Role: Co-I

      NIH RO1 AR055924 (Bikle) 09/22/08-08/31/14
      Integrin regulation of IGF-I responsiveness in bone
      This project examines how integrins regulate the response of bone to mechanical unloading
      Role: Co-I

      NIH RO1 DK054793 (Bikle) 09/12/09-08/31/14
      IGF-I mediates the anabolic effects of PTH on bone
      This project is examining the ability of PTH to stimulate bone formation in a mouse lacking a functional IGF-I or IGF-IR gene.
      Role: Co-I

      Collapse Interests
      Aging, bone, nutrition, skeletal mechanical loading, heterotopic ossification, orthopedic device development

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Awarded Grants
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Shahnazari M, Turner RT, Iwaniec UT, Wronski TJ, Li M, Ferruzzi MG, Nissenson RA, Halloran BP. Dietary dried plum increases bone mass, suppresses proinflammatory cytokines and promotes attainment of peak bone mass in male mice. J Nutr Biochem. 2016 Aug; 34:73-82. PMID: 27239754.
        View in: PubMed
      2. Schreurs AS, Shirazi-Fard Y, Shahnazari M, Alwood JS, Truong TA, Tahimic CG, Limoli CL, Turner ND, Halloran B, Globus RK. Dried plum diet protects from bone loss caused by ionizing radiation. Sci Rep. 2016; 6:21343. PMID: 26867002.
        View in: PubMed
      3. Wang L, Carroll DO, Liu X, Roth T, Kim H, Halloran B, Nissenson RA. Effects of blockade of endogenous Gi signaling in Tie2-expressing cells on bone formation in a mouse model of heterotopic ossification. J Orthop Res. 2015 Aug; 33(8):1212-7. PMID: 25773760.
        View in: PubMed
      4. Kang H, Dang AB, Joshi SK, Halloran B, Nissenson R, Zhang X, Li J, Kim HT, Liu X. Novel mouse model of spinal cord injury-induced heterotopic ossification. J Rehabil Res Dev. 2014; 51(7):1109-18. PMID: 25436890.
        View in: PubMed
      5. Smith BJ, Graef JL, Wronski TJ, Rendina E, Williams AA, Clark KA, Clarke SL, Lucas EA, Halloran BP. Effects of dried plum supplementation on bone metabolism in adult C57BL/6 male mice. Calcif Tissue Int. 2014 Apr; 94(4):442-53. PMID: 24357047; PMCID: PMC3950615.
      6. Liu X, Kang H, Shahnazari M, Kim H, Wang L, Larm O, Adolfsson L, Nissenson R, Halloran B. A novel mouse model of trauma induced heterotopic ossification. J Orthop Res. 2014 Feb; 32(2):183-8. PMID: 24136593.
        View in: PubMed
      7. Shahnazari M, Chu V, Wronski TJ, Nissenson RA, Halloran BP. CXCL12/CXCR4 signaling in the osteoblast regulates the mesenchymal stem cell and osteoclast lineage populations. FASEB J. 2013 Sep; 27(9):3505-13. PMID: 23704087.
        View in: PubMed
      8. Rendina E, Hembree KD, Davis MR, Marlow D, Clarke SL, Halloran BP, Lucas EA, Smith BJ. Dried plum's unique capacity to reverse bone loss and alter bone metabolism in postmenopausal osteoporosis model. PLoS One. 2013; 8(3):e60569. PMID: 23555991; PMCID: PMC3612052.
      9. Harris C, Roohk DJ, Fitch M, Boudignon BM, Halloran BP, Hellerstein MK. Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cycling. Am J Physiol Endocrinol Metab. 2013 Feb 1; 304(3):E282-93. PMID: 23211515; PMCID: PMC3566431.
      10. Shahnazari M, Kurimoto P, Boudignon BM, Orwoll BE, Bikle DD, Halloran BP. Simulated spaceflight produces a rapid and sustained loss of osteoprogenitors and an acute but transitory rise of osteoclast precursors in two genetic strains of mice. Am J Physiol Endocrinol Metab. 2012 Dec 1; 303(11):E1354-62. PMID: 23047986; PMCID: PMC3774081.
      11. Shahnazari M, Wronski T, Chu V, Williams A, Leeper A, Stolina M, Ke HZ, Halloran B. Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody. Calcif Tissue Int. 2012 Jul; 91(1):50-8. PMID: 22644321.
        View in: PubMed
      12. Long RK, Nishida S, Kubota T, Wang Y, Sakata T, Elalieh HZ, Halloran BP, Bikle DD. Skeletal unloading-induced insulin-like growth factor 1 (IGF-1) nonresponsiveness is not shared by platelet-derived growth factor: the selective role of integrins in IGF-1 signaling. J Bone Miner Res. 2011 Dec; 26(12):2948-58. PMID: 21932337; PMCID: PMC3222734.
      13. Shahnazari M, Dwyer D, Chu V, Asuncion F, Stolina M, Ominsky M, Kostenuik P, Halloran B. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Bone. 2012 Mar; 50(3):628-37. PMID: 22154841.
        View in: PubMed
      14. Halloran BP, Wronski TJ, VonHerzen DC, Chu V, Xia X, Pingel JE, Williams AA, Smith BJ. Dietary dried plum increases bone mass in adult and aged male mice. J Nutr. 2010 Oct; 140(10):1781-7. PMID: 20739449.
        View in: PubMed
      15. Hsiao EC, Boudignon BM, Halloran BP, Nissenson RA, Conklin BR. Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation. J Bone Miner Res. 2010 Mar; 25(3):584-93. PMID: 20200944; PMCID: PMC3153396.
      16. Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, Kingery WS. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption. Bone. 2010 May; 46(5):1369-79. PMID: 19962460; PMCID: PMC2854244.
      17. Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, Jacobs CR, Kingery WS. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone. 2009 Aug; 45(2):309-20. PMID: 19379851; PMCID: PMC2706279.
      18. Hsiao EC, Boudignon BM, Chang WC, Bencsik M, Peng J, Nguyen TD, Manalac C, Halloran BP, Conklin BR, Nissenson RA. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci U S A. 2008 Jan 29; 105(4):1209-14. PMID: 18212126; PMCID: PMC2234117.
      19. Peng J, Bencsik M, Louie A, Lu W, Millard S, Nguyen P, Burghardt A, Majumdar S, Wronski TJ, Halloran B, Conklin BR, Nissenson RA. Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinology. 2008 Mar; 149(3):1329-37. PMID: 18048501; PMCID: PMC2275363.
      20. Wang Y, Nishida S, Boudignon BM, Burghardt A, Elalieh HZ, Hamilton MM, Majumdar S, Halloran BP, Clemens TL, Bikle DD. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res. 2007 Sep; 22(9):1329-37. PMID: 17539737.
        View in: PubMed
      21. Cao JJ, Kurimoto P, Boudignon B, Rosen C, Lima F, Halloran BP. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J Bone Miner Res. 2007 Aug; 22(8):1271-9. PMID: 17488198.
        View in: PubMed
      22. Boudignon BM, Bikle DD, Kurimoto P, Elalieh H, Nishida S, Wang Y, Burghardt A, Majumdar S, Orwoll BE, Rosen C, Halloran BP. Insulin-like growth factor I stimulates recovery of bone lost after a period of skeletal unloading. J Appl Physiol (1985). 2007 Jul; 103(1):125-31. PMID: 17412794.
        View in: PubMed
      23. Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD. Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res. 2006 Sep; 21(9):1350-8. PMID: 16939393.
        View in: PubMed
      24. Wang Y, Nishida S, Sakata T, Elalieh HZ, Chang W, Halloran BP, Doty SB, Bikle DD. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology. 2006 Oct; 147(10):4753-61. PMID: 16857753.
        View in: PubMed
      25. Kazakia GJ, Nauman EA, Ebenstein DM, Halloran BP, Keaveny TM. Effects of in vitro bone formation on the mechanical properties of a trabeculated hydroxyapatite bone substitute. J Biomed Mater Res A. 2006 Jun 15; 77(4):688-99. PMID: 16514602.
        View in: PubMed
      26. Wang Y, Sakata T, Elalieh HZ, Munson SJ, Burghardt A, Majumdar S, Halloran BP, Bikle DD. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I. J Endocrinol. 2006 May; 189(2):279-87. PMID: 16648295.
        View in: PubMed
      27. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res. 2005 Sep; 20(9):1659-68. PMID: 16059637.
        View in: PubMed
      28. Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon LY, Halloran BP. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res. 2005 Jan; 20(1):30-40. PMID: 15619667.
        View in: PubMed
      29. Sakata T, Wang Y, Halloran BP, Elalieh HZ, Cao J, Bikle DD. Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways. J Bone Miner Res. 2004 Mar; 19(3):436-46. PMID: 15040832.
        View in: PubMed
      30. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004 Feb; 19(2):235-44. PMID: 14969393.
        View in: PubMed
      31. Nauman EA, Sakata T, Keaveny TM, Halloran BP, Bikle DD. bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells. Calcif Tissue Int. 2003 Aug; 73(2):147-52. PMID: 14565596.
        View in: PubMed
      32. Sakata T, Halloran BP, Elalieh HZ, Munson SJ, Rudner L, Venton L, Ginzinger D, Rosen CJ, Bikle DD. Skeletal unloading induces resistance to insulin-like growth factor I on bone formation. Bone. 2003 Jun; 32(6):669-80. PMID: 12810174.
        View in: PubMed
      33. Bikle DD, Sakata T, Halloran BP. The impact of skeletal unloading on bone formation. Gravit Space Biol Bull. 2003 Jun; 16(2):45-54. PMID: 12959131.
        View in: PubMed
      34. Cao J, Venton L, Sakata T, Halloran BP. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res. 2003 Feb; 18(2):270-7. PMID: 12568404.
        View in: PubMed
      35. Nauman EA, Ebenstein DM, Hughes KF, Pruitt L, Halloran BP, Bikle DD, Keaveny TM. Mechanical and chemical characteristics of mineral produced by basic fibroblast growth factor-treated bone marrow stromal cells in vitro. Tissue Eng. 2002 Dec; 8(6):931-9. PMID: 12542939.
        View in: PubMed
      36. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res. 2002 Sep; 17(9):1570-8. PMID: 12211426.
        View in: PubMed
      37. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res. 2002 Jun; 17(6):1044-50. PMID: 12054159.
        View in: PubMed
      38. Kahn AJ, Halloran B, Wolkowitz O, Brizendine L. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab. 2002 Apr; 87(4):1544-9. PMID: 11932279.
        View in: PubMed
      39. Halloran B, Udén P, Duh QY, Kikuchi S, Wieder T, Cao J, Clark O. Parathyroid gland volume increases with postmaturational aging in the rat. Am J Physiol Endocrinol Metab. 2002 Mar; 282(3):E557-63. PMID: 11832357.
        View in: PubMed
      40. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B. The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res. 2001 Dec; 16(12):2320-9. PMID: 11760848.
        View in: PubMed
      41. Vajda EG, Wronski TJ, Halloran BP, Bachus KN, Miller SC. Spaceflight alters bone mechanics and modeling drifts in growing rats. Aviat Space Environ Med. 2001 Aug; 72(8):720-6. PMID: 11506233.
        View in: PubMed
      42. Rabkin BA, Szivek JA, Schonfeld JE, Halloran BP. Long-term measurement of bone strain in vivo: the rat tibia. J Biomed Mater Res. 2001 May 1; 58(3):277-81. PMID: 11319741.
        View in: PubMed
      43. Nauman EA, Satcher RL, Keaveny TM, Halloran BP, Bikle DD. Osteoblasts respond to pulsatile fluid flow with short-term increases in PGE(2) but no change in mineralization. J Appl Physiol (1985). 2001 May; 90(5):1849-54. PMID: 11299276.
        View in: PubMed
      44. Howe EE, Wronski TJ, Halloran BP, Miller SC. Histologic changes in the adrenal cortex from young rats following spaceflight. Aviat Space Environ Med. 2000 Oct; 71(10):1039-44. PMID: 11051311.
        View in: PubMed
      45. Morey-Holton ER, Halloran BP, Garetto LP, Doty SB. Animal housing influences the response of bone to spaceflight in juvenile rats. J Appl Physiol (1985). 2000 Apr; 88(4):1303-9. PMID: 10749823.
        View in: PubMed
      46. Dehority W, Halloran BP, Bikle DD, Curren T, Kostenuik PJ, Wronski TJ, Shen Y, Rabkin B, Bouraoui A, Morey-Holton E. Bone and hormonal changes induced by skeletal unloading in the mature male rat. Am J Physiol. 1999 Jan; 276(1 Pt 1):E62-9. PMID: 9886951.
        View in: PubMed
      47. Bikle DD, Halloran BP. The response of bone to unloading. J Bone Miner Metab. 1999; 17(4):233-44. PMID: 10575587.
        View in: PubMed
      48. Kostenuik PJ, Harris J, Halloran BP, Turner RT, Morey-Holton ER, Bikle DD. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J Bone Miner Res. 1999 Jan; 14(1):21-31. PMID: 9893062.
        View in: PubMed
      49. Turner RT, Evans GL, Cavolina JM, Halloran B, Morey-Holton E. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats. Endocrinology. 1998 Oct; 139(10):4086-91. PMID: 9751486.
        View in: PubMed
      50. Wronski TJ, Li M, Shen Y, Miller SC, Bowman BM, Kostenuik P, Halloran BP. Lack of effect of spaceflight on bone mass and bone formation in group-housed rats. J Appl Physiol (1985). 1998 Jul; 85(1):279-85. PMID: 9655787.
        View in: PubMed
      51. Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD, Cann CE, King JC. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr. 1998 Apr; 67(4):693-701. PMID: 9537616.
        View in: PubMed
      52. Kostenuik PJ, Halloran BP, Morey-Holton ER, Bikle DD. Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells. Am J Physiol. 1997 Dec; 273(6 Pt 1):E1133-9. PMID: 9435529.
        View in: PubMed
      53. Halloran BP, Bikle DD, Harris J, Tanner S, Curren T, Morey-Holton E. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. J Bone Miner Res. 1997 Jul; 12(7):1068-74. PMID: 9200006.
        View in: PubMed
      54. Bikle DD, Halloran BP, Morey-Holton E. Spaceflight and the skeleton: lessons for the earthbound. Gravit Space Biol Bull. 1997 Jun; 10(2):119-35. PMID: 11540113.
        View in: PubMed
      55. Autry CP, Kifor O, Brown EM, Fuller FH, Rogers KV, Halloran BP. Ca2+ receptor mRNA and protein increase in the rat parathyroid gland with advancing age. J Endocrinol. 1997 Jun; 153(3):437-44. PMID: 9203998.
        View in: PubMed
      56. Bikle DD, Halloran BP, Morey-Holton E. Space flight and the skeleton: lessons for the earthbound. Endocrinologist. 1997 Jan-Feb; 7(1):10-22. PMID: 11540416.
        View in: PubMed
      57. Portale AA, Lonergan ET, Tanney DM, Halloran BP. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. Am J Physiol. 1997 Jan; 272(1 Pt 1):E139-46. PMID: 9038863.
        View in: PubMed
      58. Li M, Shen Y, Halloran BP, Baumann BD, Miller K, Wronski TJ. Skeletal response to corticosteroid deficiency and excess in growing male rats. Bone. 1996 Aug; 19(2):81-8. PMID: 8853849.
        View in: PubMed
      59. Halloran BP, Lonergan ET, Portale AA. Aging and renal responsiveness to parathyroid hormone in healthy men. J Clin Endocrinol Metab. 1996 Jun; 81(6):2192-7. PMID: 8964850.
        View in: PubMed
      60. Portale AA, Halloran BP, Morris RC, Lonergan ET. Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men. Am J Physiol. 1996 Mar; 270(3 Pt 1):E483-90. PMID: 8638697.
        View in: PubMed
      61. Halloran BP, Bikle DD, Harris J, Autry CP, Currier PA, Tanner S, Patterson-Buckendahl P, Morey-Holton E. Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone. J Bone Miner Res. 1995 Aug; 10(8):1168-76. PMID: 8585419.
        View in: PubMed
      62. Bikle DD, Harris J, Halloran BP, Currier PA, Tanner S, Morey-Holton E. The molecular response of bone to growth hormone during skeletal unloading: regional differences. Endocrinology. 1995 May; 136(5):2099-109. PMID: 7720659.
        View in: PubMed
      63. Bikle DD, Harris J, Halloran BP, Morey-Holton E. Altered skeletal pattern of gene expression in response to spaceflight and hindlimb elevation. Am J Physiol. 1994 Dec; 267(6 Pt 1):E822-7. PMID: 7810622.
        View in: PubMed
      64. Bikle DD, Morey-Holton ER, Doty SB, Currier PA, Tanner SJ, Halloran BP. Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage. J Bone Miner Res. 1994 Nov; 9(11):1777-87. PMID: 7863829.
        View in: PubMed
      65. Bikle DD, Harris J, Halloran BP, Morey-Holton ER. Skeletal unloading induces resistance to insulin-like growth factor I. J Bone Miner Res. 1994 Nov; 9(11):1789-96. PMID: 7532347.
        View in: PubMed
      66. Bikle DD, Harris J, Halloran BP, Roberts CT, Leroith D, Morey-Holton E. Expression of the genes for insulin-like growth factors and their receptors in bone during skeletal growth. Am J Physiol. 1994 Aug; 267(2 Pt 1):E278-86. PMID: 8074208.
        View in: PubMed
      67. Bikle DD, Halloran BP, Morey-Holton E. Impact of skeletal unloading on bone formation: role of systemic and local factors. Acta Astronaut. 1994 Jul; 33:119-29. PMID: 11539511.
        View in: PubMed
      68. Bikle DD, Halloran BP, Riviere JE. Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol. 1994 May; 102(5):796-8. PMID: 8176265.
        View in: PubMed
      69. Halloran BP. Cellular growth and differentiation during embryogenesis and fetal development. The role of vitamin D. Adv Exp Med Biol. 1994; 352:227-36. PMID: 7832052.
        View in: PubMed
      70. Bikle DD, Stesin A, Halloran B, Steinbach L, Recker R. Alcohol-induced bone disease: relationship to age and parathyroid hormone levels. Alcohol Clin Exp Res. 1993 Jun; 17(3):690-5. PMID: 8333602.
        View in: PubMed
      71. Halloran BP, Bikle DD, Harris J, Foskett HC, Morey-Holton E. Skeletal unloading decreases production of 1,25-dihydroxyvitamin D. Am J Physiol. 1993 May; 264(5 Pt 1):E712-6. PMID: 8498493.
        View in: PubMed
      72. Bikle DD, Halloran B, Fong L, Steinbach L, Shellito J. Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone. J Clin Endocrinol Metab. 1993 Feb; 76(2):456-61. PMID: 8432789.
        View in: PubMed
      73. Portale AA, Halloran BP, Harris ST, Bikle DD, Morris RC. Metabolic acidosis reverses the increase in serum 1,25(OH)2D in phosphorus-restricted normal men. Am J Physiol. 1992 Dec; 263(6 Pt 1):E1164-70. PMID: 1476189.
        View in: PubMed
      74. Udén P, Halloran B, Daly R, Duh QY, Clark O. Set-point for parathyroid hormone release increases with postmaturational aging in the rat. Endocrinology. 1992 Nov; 131(5):2251-6. PMID: 1425424.
        View in: PubMed
      75. Bikle DD, Halloran BP, Harris ST, Portale AA. Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels. J Clin Endocrinol Metab. 1992 Aug; 75(2):519-23. PMID: 1639954.
        View in: PubMed
      76. Wada L, Daly R, Kern D, Halloran B. Kinetics of 1,25-dihydroxyvitamin D metabolism in the aging rat. Am J Physiol. 1992 Jun; 262(6 Pt 1):E906-10. PMID: 1616024.
        View in: PubMed
      77. Grady D, Halloran B, Cummings S, Leveille S, Wells L, Black D, Byl N. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. J Clin Endocrinol Metab. 1991 Nov; 73(5):1111-7. PMID: 1939527.
        View in: PubMed
      78. Stein B, Halloran BP, Reinhardt T, Engstrom GW, Bales CW, Drezner MK, Currie KL, Takizawa M, Adams JS, Epstein S. Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse. Endocrinology. 1991 Mar; 128(3):1369-73. PMID: 1999158.
        View in: PubMed
      79. Bikle DD, Halloran BP, McGalliard-Cone C, Morey-Holton E. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion. Am J Physiol. 1990 Nov; 259(5 Pt 1):E715-22. PMID: 2240210.
        View in: PubMed
      80. Halloran BP, Portale AA, Lonergan ET, Morris RC. Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age. J Clin Endocrinol Metab. 1990 Feb; 70(2):318-23. PMID: 2298850.
        View in: PubMed
      81. Sessions ND, Halloran BP, Bikle DD, Wronski TJ, Cone CM, Morey-Holton E. Bone response to normal weight bearing after a period of skeletal unloading. Am J Physiol. 1989 Oct; 257(4 Pt 1):E606-10. PMID: 2801939.
        View in: PubMed
      82. Budayr AA, Halloran BP, King JC, Diep D, Nissenson RA, Strewler GJ. High levels of a parathyroid hormone-like protein in milk. Proc Natl Acad Sci U S A. 1989 Sep; 86(18):7183-5. PMID: 2550932; PMCID: PMC298020.
      83. Halloran BP. Is 1,25-dihydroxyvitamin D required for reproduction? Proc Soc Exp Biol Med. 1989 Jul; 191(3):227-32. PMID: 2662198.
        View in: PubMed
      84. Halloran BP, Castro ME. Vitamin D kinetics in vivo: effect of 1,25-dihydroxyvitamin D administration. Am J Physiol. 1989 May; 256(5 Pt 1):E686-91. PMID: 2785765.
        View in: PubMed
      85. Portale AA, Halloran BP, Morris RC. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest. 1989 May; 83(5):1494-9. PMID: 2708521; PMCID: PMC303852.
      86. Halloran BP, Bikle DD, Castro ME, Gee E. Isotopic labeling affects 1,25-dihydroxyvitamin D metabolism. Biochemistry. 1989 Feb 7; 28(3):1278-81. PMID: 2713363.
        View in: PubMed
      87. Halloran BP, Bikle DD, Cone CM, Morey-Holton E. Glucocorticoids and inhibition of bone formation induced by skeletal unloading. Am J Physiol. 1988 Dec; 255(6 Pt 1):E875-9. PMID: 3202163.
        View in: PubMed
      88. Halloran BP, Spencer EM. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology. 1988 Sep; 123(3):1225-9. PMID: 3402383.
        View in: PubMed
      89. Portale AA, Halloran BP, Morris RC. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest. 1987 Oct; 80(4):1147-54. PMID: 3654974; PMCID: PMC442358.
      90. Feingold KR, Williams ML, Pillai S, Menon GK, Halloran BP, Bikle DD, Elias PM. The effect of vitamin D status on cutaneous sterologenesis in vivo and in vitro. Biochim Biophys Acta. 1987 Sep 14; 930(2):193-200. PMID: 3040120.
        View in: PubMed
      91. Bikle DD, Halloran BP, Cone CM, Globus RK, Morey-Holton E. The effects of simulated weightlessness on bone maturation. Endocrinology. 1987 Feb; 120(2):678-84. PMID: 3803298.
        View in: PubMed
      92. Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinology. 1986 Dec; 119(6):2580-5. PMID: 3780540.
        View in: PubMed
      93. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986 Oct; 63(4):954-9. PMID: 3745408.
        View in: PubMed
      94. Halloran BP, Bikle DD, Levens MJ, Castro ME, Globus RK, Holton E. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. J Clin Invest. 1986 Sep; 78(3):622-8. PMID: 3489007; PMCID: PMC423635.
      95. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest. 1986 Sep; 78(3):748-52. PMID: 3745436; PMCID: PMC423667.
      96. Strewler GJ, Wronski TJ, Halloran BP, Miller SC, Leung SC, Williams RD, Nissenson RA. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma. Endocrinology. 1986 Jul; 119(1):303-10. PMID: 3013591.
        View in: PubMed
      97. Globus RK, Bikle DD, Halloran B, Morey-Holton E. Skeletal response to dietary calcium in a rat model simulating weightlessness. J Bone Miner Res. 1986 Apr; 1(2):191-7. PMID: 3503537.
        View in: PubMed
      98. Halloran BP, Bikle DD, Wronski TJ, Globus RK, Levens MJ, Morey-Holton E. The role of 1,25-dihydroxyvitamin D in the inhibition of bone formation induced by skeletal unloading. Endocrinology. 1986 Mar; 118(3):948-54. PMID: 3485043.
        View in: PubMed
      99. Portale AA, Halloran BP, Murphy MM, Morris RC. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest. 1986 Jan; 77(1):7-12. PMID: 3753709; PMCID: PMC423300.
      100. Bikle DD, Halloran BP, Cone CM, Morey-Holton E. Bone loss during simulated weightlessness: is it glucocorticoid mediated? Physiologist. 1985 Dec; 28(6 Suppl):S123-4. PMID: 3834430.
        View in: PubMed
      101. Halloran BP, Bikle DD, Wronski TJ, Globus RK, Levens MJ, Morey-Holton E. Effect of simulated weightlessness and chronic 1,25-dihydroxyvitamin D administration on bone metabolism. Physiologist. 1985 Dec; 28(6 Suppl):S127-8. PMID: 3841737.
        View in: PubMed
      102. Hulter HN, Halloran BP, Toto RD, Peterson JC. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest. 1985 Aug; 76(2):695-702. PMID: 3928683; PMCID: PMC423880.
      103. Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med. 1985 Jul; 103(1):42-8. PMID: 2988390.
        View in: PubMed
      104. Halloran BP, Portale AA, Castro M, Morris RC, Goldsmith RS. Serum concentration of 1,25-dihydroxyvitamin D in the human: diurnal variation. J Clin Endocrinol Metab. 1985 Jun; 60(6):1104-10. PMID: 3998063.
        View in: PubMed
      105. Bikle DD, Halloran BP, Whitney JO, Hollis BW. Measurement of 25,26-dihydroxyvitamin D: importance of the configuration of the C-25 hydroxyl group. Biochemistry. 1984 Dec 18; 23(26):6920-5. PMID: 6543324.
        View in: PubMed
      106. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984 Dec; 74(6):1966-71. PMID: 6549014; PMCID: PMC425383.
      107. Halloran BP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984 Dec; 59(6):1063-9. PMID: 6333430.
        View in: PubMed
      108. Halloran BP, Bikle DD, Whitney JO. Separation of isotopically labeled vitamin D metabolites by high-performance liquid chromatography. J Chromatogr. 1984 Oct 26; 303(1):229-33. PMID: 6511833.
        View in: PubMed
      109. Portale AA, Booth BE, Halloran BP, Morris RC. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984 Jun; 73(6):1580-9. PMID: 6547151; PMCID: PMC437069.
      110. Armbrecht HJ, Forte LR, Halloran BP. Effect of age and dietary calcium on renal 25(OH)D metabolism, serum 1,25(OH)2D, and PTH. Am J Physiol. 1984 Mar; 246(3 Pt 1):E266-70. PMID: 6608276.
        View in: PubMed
      111. Hulter HN, Toto RD, Ilnicki LP, Halloran B, Sebastian A. Metabolic alkalosis in models of primary and secondary hyperparathyroid states. Am J Physiol. 1983 Oct; 245(4):F450-61. PMID: 6414311.
        View in: PubMed
      112. Gogel E, Halloran BP, Strewler GJ. Probenecid inhibits the secretion of nephrogenous adenosine 3',5'-monophosphate in normal man. J Clin Endocrinol Metab. 1983 Oct; 57(4):689-93. PMID: 6309880.
        View in: PubMed
      113. Miller SC, Halloran BP, DeLuca HF, Jee WS. Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int. 1983 Jul; 35(4-5):455-60. PMID: 6616315.
        View in: PubMed
      114. Stern PH, Halloran BP, DeLuca HF, Hefley TJ. Responsiveness of vitamin D-deficient fetal rat limb bones to parathyroid hormone in culture. Am J Physiol. 1983 Apr; 244(4):E421-4. PMID: 6687660.
        View in: PubMed
      115. Bikle DD, Herman RH, Hull S, Hagler L, Harris D, Halloran B. Adaptive response of humans to changes in dietary calcium: relationship between vitamin D regulated intestinal function and serum 1,25-dihydroxyvitamin D levels. Gastroenterology. 1983 Feb; 84(2):314-23. PMID: 6687358.
        View in: PubMed
      116. Miller SC, Halloran BP, DeLuca HF, Jee WS. Role of vitamin D in maternal skeletal changes during pregnancy and lactation: a histomorphometric study. Calcif Tissue Int. 1982 May; 34(3):245-52. PMID: 6809285.
        View in: PubMed
      117. DeLuca HF, Franceschi RT, Halloran BP, Massaro ER. Molecular events involved in 1,25-dihydroxyvitamin D3 stimulation of intestinal calcium transport. Fed Proc. 1982 Jan; 41(1):66-71. PMID: 6276233.
        View in: PubMed
      118. Halloran BP, DeLuca HF. Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. J Biol Chem. 1981 Jul 25; 256(14):7338-42. PMID: 6265444.
        View in: PubMed
      119. Halloran BP, DeLuca HF, Barthell E, Yamada S, Ohmori M, Takayama H. An examination of the importance of 24-hydroxylation to the function of vitamin D during early development. Endocrinology. 1981 Jun; 108(6):2067-71. PMID: 6894423.
        View in: PubMed
      120. Halloran BP, De Luca HF. Effect of vitamin D deficiency on skeletal development during early growth in the rat. Arch Biochem Biophys. 1981 Jun; 209(1):7-14. PMID: 7283447.
        View in: PubMed
      121. Halloran BP, De Luca HF. Intestinal calcium transport: evidence for two distinct mechanisms of action of 1,25-dihydroxyvitamin D3. Arch Biochem Biophys. 1981 May; 208(2):477-86. PMID: 6894839.
        View in: PubMed
      122. Miller SC, Halloran BP, DeLuca HF, Yamada S, Takayama H, Jee WS. Studies on the role of 24-hydroxylation of vitamin D in the mineralization of cartilage and bone of vitamin D-deficient rats. Calcif Tissue Int. 1981; 33(5):489-97. PMID: 6274486.
        View in: PubMed
      123. Halloran BP, DeLuca HF. Skeletal changes during pregnancy and lactation: the role of vitamin D. Endocrinology. 1980 Dec; 107(6):1923-9. PMID: 7428698.
        View in: PubMed
      124. Halloran BP, DeLuca HF. Calcium transport in small intestine during early development: role of vitamin D. Am J Physiol. 1980 Dec; 239(6):G473-9. PMID: 7446740.
        View in: PubMed
      125. Halloran BP, DeLuca HF. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr. 1980 Aug; 110(8):1573-80. PMID: 7400847.
        View in: PubMed
      126. Halloran BP, DeLuca HF. Calcium transport in small intestine during pregnancy and lactation. Am J Physiol. 1980 Jul; 239(1):E64-8. PMID: 6249126.
        View in: PubMed
      127. Halloran BP, Barthell EN, DeLuca HF. Vitamin D metabolism during pregnancy and lactation in the rat. Proc Natl Acad Sci U S A. 1979 Nov; 76(11):5549-53. PMID: 293660; PMCID: PMC411686.
      128. Tanaka Y, Halloran B, Schnoes HK, DeLuca HF. In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):5033-5. PMID: 291919; PMCID: PMC413073.
      129. Halloran BP, DeLuca HF. Vitamin D deficiency and reproduction in rats. Science. 1979 Apr 6; 204(4388):73-4. PMID: 432628.
        View in: PubMed
      Bernard's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP